RALEIGH, NC--(Marketwired - March 05, 2014) - DARA BioSciences, Inc. (DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio ...
Since its approval in 1977, tamoxifen has been used to treat millions of women and men diagnosed with hormone-receptor-positive breast cancer. Treatment with tamoxifen lowers the risk of breast cancer ...
Breast Cancer Awareness Month raises visibility and research dollars to address a disease that in the United States claims nearly 40,000 lives annually and affects approximately 240,000 people who ...
RALEIGH, NC--(Marketwired - May 08, 2014) - DARA BioSciences, Inc. (DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio ...
(Nasdaq:DARA) announced today that it has entered into an exclusive distribution agreement with for the sale and distribution of (tamoxifen citrate, oral solution) in the Commonwealth of Puerto Rico.
In our view, the DARA story is really starting to come together. We see Soltamox as a $25 million peak opportunity for DARA Bio. Soltamox is a U.S. FDA approved (in 2006) oral liquid formulation of ...
Federal regulators have cited Raleigh-based Dara BioSciences for running misleading sales ads for Soltamox, an oral liquid formulation used in the treatment and prevention of breast cancer. In a ...
RALEIGH, NC--(Marketwired - March 05, 2014) - DARA BioSciences, Inc. (DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio ...
RALEIGH, N.C.--(BUSINESS WIRE)-- DARA BioSciences, Inc. (NAS: DARA) , a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it has launched ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback